Rockwell Medical Named a Fortune 'Best Workplaces in Manufacturing & Production'
18 9월 2024 - 7:00PM
Business Wire
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a
healthcare company that develops, manufactures, commercializes, and
distributes a portfolio of hemodialysis products to dialysis
providers worldwide, today announced that Great Place to Work® and
Fortune magazine selected Rockwell Medical for the 2024 Fortune
Best Workplaces in Manufacturing and ProductionTM List in the small
& medium category.
"It is an honor for Rockwell Medical to be named one of the best
companies to work for in the country," said Lesley Spriggs, Vice
President of Human Resources at Rockwell Medical. "We have great
leaders who care about each and every employee. I am incredibly
proud of the talented team we have d at Rockwell Medical and am
grateful for their continued commitment and dedication to
manufacturing and delivering life-sustaining dialysis solutions to
vulnerable patients with end-stage kidney disease."
About Fortune
Fortune upholds a legacy of award-winning writing and trusted
reporting for executives who want to make business better.
Independently owned, with a global perspective and digital agility,
Fortune tells the stories of a new generation of innovators,
builders, and risk takers. Online and in print, Fortune measures
corporate performance through rigorous benchmarks and holds
companies accountable. Fortune creates communities by convening
true thought leaders and iconoclasts — those who shape industry,
commerce, and society – through powerful and prestigious lists,
events, and conferences, such as the iconic Fortune 500, the CEO
Initiative, and Most Powerful Women. For more information, visit
fortune.com.
About Rockwell Medical
Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company
that develops, manufactures, commercializes, and distributes a
portfolio of hemodialysis products for dialysis providers
worldwide. Rockwell Medical's mission is to provide dialysis
clinics and the patients they serve with the highest quality
products supported by the best customer service in the industry.
Rockwell is focused on innovative, long-term growth strategies that
enhance its products, its processes, and its people, enabling the
Company to deliver exceptional value to the healthcare system and
provide a positive impact on the lives of hemodialysis patients.
Hemodialysis is the most common form of end-stage kidney disease
treatment and is typically performed at freestanding outpatient
dialysis centers, hospital-based outpatient centers, skilled
nursing facilities, or in a patient’s home. Rockwell Medical's
products are vital to vulnerable patients with end-stage kidney
disease, and the Company is relentless in providing unmatched
reliability and customer service. Certified as a Great Place to
Work® in 2023 and 2024 and named Fortune Best Workplaces in
Manufacturing & ProductionTM in 2024, Rockwell Medical is
Driven to Deliver Life-Sustaining Dialysis SolutionsTM. For more
information, visit www.rockwellmed.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240918495430/en/
Heather R. Hunter SVP, Chief Corporate Affairs Officer (248)
432-1362 IR@RockwellMed.com
Rockwell Medical (NASDAQ:RMTI)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Rockwell Medical (NASDAQ:RMTI)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024